IRAK1 and neoplasm: (2024) demonstrated that inhibition of AHR, together with IRAK1, downregulates the immune checkpoint regulator VISTA and reprograms tumor-associated macrophages toward a proinflammatory, antitumor phenotype (48) supporting the concept that AHR modulation influences macrophage polarization patterns in PBMC-derived monocytes.